Live feed
Filing
SC 13D/A
SC 13D/A0001104659-22-086368·Addex Therapeutics Ltd.
Schedule 13D ownership disclosure
ADDEX THERAPEUTICS LTD
Security class unavailable · CUSIP: 00654J107
Event date: 2022-07-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,460,500
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-086368
- Form type
- SC 13D/A
- Filer
- Addex Therapeutics Ltd.
- CIK
- CIK 1574232
- Filed
- Aug 05, 2022
- Reporting period
- Jul 26, 2022
- Description
- Schedule 13D beneficial ownership